These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 24789770
1. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. De A, Guryev I, LaRiviere A, Kato R, Wee CP, Mascarenhas L, Keens TG, Venkatramani R. Pediatr Blood Cancer; 2014 Sep; 61(9):1679-84. PubMed ID: 24789770 [Abstract] [Full Text] [Related]
2. Bleomycin-associated Lung Toxicity in Childhood Cancer Survivors. Zorzi AP, Yang CL, Dell S, Nathan PC. J Pediatr Hematol Oncol; 2015 Nov; 37(8):e447-52. PubMed ID: 26422284 [Abstract] [Full Text] [Related]
3. Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Mulder RL, Thönissen NM, van der Pal HJ, Bresser P, Hanselaar W, Koning CC, Oldenburger F, Heij HA, Caron HN, Kremer LC. Thorax; 2011 Dec; 66(12):1065-71. PubMed ID: 21803931 [Abstract] [Full Text] [Related]
4. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. Int J Radiat Oncol Biol Phys; 2013 Aug 01; 86(5):942-8. PubMed ID: 23726005 [Abstract] [Full Text] [Related]
5. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity. Jóna Á, Miltényi Z, Ujj Z, Garai I, Szilasi M, Illés Á. Expert Opin Drug Saf; 2014 Oct 01; 13(10):1291-7. PubMed ID: 25135756 [Abstract] [Full Text] [Related]
6. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman. Ahmed BM, Al-Zakwani IS. J Oncol Pharm Pract; 2013 Mar 01; 19(1):3-7. PubMed ID: 22504168 [Abstract] [Full Text] [Related]
7. Pulmonary complications in survivors of childhood hematological malignancies: single-center experience. Tantawy AA, Elbarbary N, Ahmed A, Mohamed NA, Ezz-Elarab S. Pediatr Hematol Oncol; 2011 Aug 01; 28(5):403-17. PubMed ID: 21728717 [Abstract] [Full Text] [Related]
8. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. Pediatr Blood Cancer; 2014 Jul 01; 61(7):1277-81. PubMed ID: 24482138 [Abstract] [Full Text] [Related]
9. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ, ASCO Cancer Survivorship Expert Panel. J Clin Oncol; 2007 Sep 01; 25(25):3991-4008. PubMed ID: 17577017 [Abstract] [Full Text] [Related]
10. Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors. Avivi I, Hardak E, Shaham B, Igla M, Rowe JM, Dann EJ. Ann Hematol; 2012 Feb 01; 91(2):215-21. PubMed ID: 21603918 [Abstract] [Full Text] [Related]
11. Analysis of Risk Factors for Abnormal Pulmonary Function in Pediatric Cancer Survivors. Record E, Williamson R, Wasilewski-Masker K, Mertens AC, Meacham LR, Popler J. Pediatr Blood Cancer; 2016 Jul 01; 63(7):1264-71. PubMed ID: 27002916 [Abstract] [Full Text] [Related]
12. Bleomycin and pulmonary screening: many questions, few answers. Duncan CN. Pediatr Blood Cancer; 2014 Sep 01; 61(9):1527-8. PubMed ID: 24810221 [No Abstract] [Full Text] [Related]
13. Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation. De A, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Mascarenhas L, Keens TG, Venkatramani R. Pediatr Pulmonol; 2015 Jun 01; 50(6):596-603. PubMed ID: 24644268 [Abstract] [Full Text] [Related]
14. Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy. Andrade RS, Kesler KA, Wilson JL, Brooks JA, Reichwage BD, Rieger KM, Einhorn LH, Brown JW. Ann Thorac Surg; 2004 Oct 01; 78(4):1224-8; discussion 1228-9. PubMed ID: 15464475 [Abstract] [Full Text] [Related]
15. [Risk factors for lung toxicity in pediatric cancer survivors]. López Andreu JA, Compte Torrero L, Ferrís Tortajada J, Domenech Clar R, Pérez Tarazona S, Pellicer Porres C, Cortina Orts H, Roqués Serradilla JM. An Esp Pediatr; 1999 Nov 01; 51(5):505-11. PubMed ID: 10652802 [Abstract] [Full Text] [Related]
16. Bleomycin induced pulmonary toxicity in patients with germ cell tumours. Usman M, Faruqui ZS, ud Din N, Zahid KF. J Ayub Med Coll Abbottabad; 2010 Nov 01; 22(3):35-7. PubMed ID: 22338413 [Abstract] [Full Text] [Related]
17. A longitudinal analysis of early lung function trajectory in survivors of childhood Hodgkin lymphoma. Zheng K, Bassal M, Mitsakakis N, Cepalo T, Hamid JS, Momoli F, Reisman J, Nair V, Radhakrishnan D. Cancer Rep (Hoboken); 2023 Jan 01; 6(1):e1661. PubMed ID: 35760768 [Abstract] [Full Text] [Related]
18. Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma. Ngeow J, Tan IB, Kanesvaran R, Tan HC, Tao M, Quek R, Lim ST. Ann Hematol; 2011 Jan 01; 90(1):67-72. PubMed ID: 20676640 [Abstract] [Full Text] [Related]
19. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors. Kharasch VS, Lipsitz S, Santis W, Hallowell JA, Goorin A. Med Pediatr Oncol; 1996 Aug 01; 27(2):85-91. PubMed ID: 8649325 [Abstract] [Full Text] [Related]
20. Monitoring pulmonary health in Swiss childhood cancer survivors. Kasteler R, Kam LMH, Weiss A, Waespe N, Sommer G, Singer F, von der Weid NX, Ansari M, Kuehni CE, Swiss Pediatric Oncology Group (SPOG)Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Switzerland.. Pediatr Blood Cancer; 2018 Oct 01; 65(10):e27255. PubMed ID: 29905401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]